End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
5,486 MXN | +1.67% | +1.67% | -1.68% |
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
- Analysts' price targets are all relatively close, reflecting good visibility on the company's valuation.
- The group usually releases upbeat results with huge surprise rates.
Weaknesses
- According to forecast, a sluggish sales growth is expected for the next fiscal years.
- With a 2024 P/E ratio at 27.24 times the estimated earnings, the company operates at rather significant levels of earnings multiples.
- Based on current prices, the company has particularly high valuation levels.
- The company appears highly valued given the size of its balance sheet.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Advanced Medical Equipment & Technology
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-1.68% | 17.45B | - | ||
+6.57% | 217B | B | ||
+11.06% | 188B | B- | ||
+28.59% | 153B | B- | ||
+32.04% | 112B | A- | ||
-0.30% | 62.84B | A- | ||
+15.84% | 52.35B | B+ | ||
+0.80% | 49.33B | B+ | ||
+1.00% | 35.4B | - | ||
+23.27% | 30.9B | B+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- WAT Stock
- WAT * Stock
- Ratings Waters Corporation